| Product NDC: | 24208-446 |
| Proprietary Name: | Besivance |
| Non Proprietary Name: | Besifloxacin |
| Active Ingredient(s): | 6 mg/mL & nbsp; Besifloxacin |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 24208-446 |
| Labeler Name: | Bausch & Lomb Incorporated |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022308 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090528 |
| Package NDC: | 24208-446-05 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (24208-446-05) > 5 mL in 1 BOTTLE, DROPPER |
| NDC Code | 24208-446-05 |
| Proprietary Name | Besivance |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (24208-446-05) > 5 mL in 1 BOTTLE, DROPPER |
| Product NDC | 24208-446 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Besifloxacin |
| Dosage Form Name | SUSPENSION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20090528 |
| Marketing Category Name | NDA |
| Labeler Name | Bausch & Lomb Incorporated |
| Substance Name | BESIFLOXACIN |
| Strength Number | 6 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |